We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
NBTX icon
126
Nanobiotix
NBTX
$1.49B
$1.49B $29.17 12.9%
OCUL icon
127
Ocular Therapeutix
OCUL
$1.45B
$1.45B $6.61 2.01%
ANAB icon
128
AnaptysBio
ANAB
$1.44B
$1.44B $48.15 0.44%
TYRA icon
129
Tyra Biosciences
TYRA
$1.44B
$1.44B $20.91 1.5%
INBX icon
130
Inhibrx
INBX
$1.42B
$1.42B $96.56 1.66%
ORIC icon
131
Oric Pharmaceuticals
ORIC
$1.41B
$1.41B $13.61 1.73%
AAPG icon
132
Ascentage Pharma
AAPG
$1.41B
$1.41B $15.10 7.59%
DMRA
133
Damora Therapeutics
DMRA
$1.34B
$1.34B $21.67 0.65%
TSHA icon
134
Taysha Gene Therapies
TSHA
$1.3B
$1.3B $4 2.91%
NKTR icon
135
Nektar Therapeutics
NKTR
$1.28B
$1.28B $37.53 1.93%
GHRS icon
136
GH Research
GHRS
$1.28B
$1.28B $18.60 1.64%
LBRX icon
137
LB Pharmaceuticals
LBRX
$1.27B
$1.27B $39.28 0.13%
RAPP icon
138
Rapport Therapeutics
RAPP
$1.25B
$1.25B $26.10 4.15%
SLN icon
139
Silence Therapeutics
SLN
$1.22B
$1.22B $19.66 0.05%
AVLN icon
140
Avalyn Pharma
AVLN
$1.22B
$1.22B $27.47 9.4%
SNDX icon
141
Syndax Pharmaceuticals
SNDX
$1.19B
$1.19B $13.38 1.75%
OMER icon
142
Omeros
OMER
$1.19B
$1.19B $16.45 1.17%
KARD
143
Kardigan Inc
KARD
$1.19B
$1.19B $12.68 1.32%
DRTS icon
144
Alpha Tau Medical
DRTS
$1.18B
$1.18B $12.81 4.97%
BCAX icon
145
Bicara Therapeutics
BCAX
$1.16B
$1.16B $17.54 2.07%
IMTX icon
146
Immatics
IMTX
$1.16B
$1.16B $7.59 1.3%
VOR icon
147
Vor Biopharma
VOR
$1.13B
$1.13B $19.09 0.79%
REPL icon
148
Replimune Group
REPL
$1.12B
$1.12B $11.91 1.62%
LTGO
149
Latigo Biotherapeutics
LTGO
$1.12B
$1.12B $16.91 3.49%
SPTX icon
150
Seaport Therapeutics
SPTX
$1.12B
$1.12B $20.91 5.98%
4 5
6
7 8

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.25T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $136B, Regeneron Pharmaceuticals (REGN) at $84.4B and Moderna (MRNA) at $74B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.